Susan Bobulsky

Insider Reports History

Entity
Individual
Location
C/O Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle, WA
Signature
/s/ Susan Bobulsky by Kyle Piskel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Bobulsky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptive Biotechnologies Corp Chief Commercial Officer, MRD Common Stock 253K $502K $1.98 Oct 8, 2024 Direct
Adaptive Biotechnologies Corp Chief Commercial Officer, MRD Stock Option (right to buy) 0 Oct 8, 2024 Direct

Insider Reports Filed by Susan Bobulsky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADPT Adaptive Biotechnologies Corp Oct 8, 2024 2 $9.9K 4 Oct 10, 2024 Chief Commercial Officer, MRD
ADPT Adaptive Biotechnologies Corp Mar 4, 2024 4 -$44.6K 4 Mar 6, 2024 Chief Commercial Officer, MRD
ADPT Adaptive Biotechnologies Corp Jan 25, 2024 0 $0 3 Mar 6, 2024 Chief Commercial Officer, MRD